GENE CYP2C19 POLYMORPHISM G681A INFLUENCE ON THE EFFICACY OF CLOPIDOGREL IN ENDOVASCULAR TREATMENT OF ISCHEMIC HEART DISEASE COMORBID WITH TYPE 2 DIABETES

QR Code

GENE CYP2C19 POLYMORPHISM G681A INFLUENCE ON THE EFFICACY OF CLOPIDOGREL IN ENDOVASCULAR TREATMENT OF ISCHEMIC HEART DISEASE COMORBID WITH TYPE 2 DIABETES

Aim. To research on the influence of polymorphism G681A gene CYP2C19 on efficacy of clopidogrel for planned endovascular treatment in stable CHD with second type diabetes.Material and methods. Totally 242 patients included, with chronic CHD, underwent planned angioplastics and stenting of coronary a...

Full description

Saved in:

Bibliographic Details
Main Authors:	A. N. Repin, T. N. Sergienko, E. F. Muslimova, E. F. Afanasyev
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2015-10-01
Series:	Российский кардиологический журнал
Subjects:	gene cyp2c19 ischemic heart disease coronary stenting platelet aggregation diabetes mellitus 2 type
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/318
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

PREVALENCE OF POLYMORPHOUS LOCUS 681G>A OF CYP2C19 GENE IN RUSSIAN POPULATION
by: T. A. Bairova, et al.
Published: (2014-11-01)

THE PROTOCOL: INFLUENCE OF THE COMBINATION CARRIAGE СУР2С19*2 AND *17 ON EFFICACY OF CLOPIDOGREL
by: Е. М. Zelenskaya, et al.
Published: (2017-11-01)

CLOPIDOGREL RESPONSE IN ACUTE CORONARY SYNDROME PATIENTS WITH CYP2Y12*2 AND CYP2Y12*3 POLYMORPHISMS
by: R. Rahmatini, et al.
Published: (2018-04-01)

THE “PROTOCOL” STUDY: PRELIMINARY RESULTS
by: E. M. Zelenskaya, et al.
Published: (2015-10-01)

CLOPIDOGREL PHARMACOGENETICS
by: A. N. Meshkov
Published: (2016-01-01)

NFLUENCE OF CYP4F2*3 ON RESPONSE TO CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROME
by: K. B. Mirzaev, et al.
Published: (2018-03-01)

INFLUENCE OF THE CYP3A4 ISOENZYME METABOLIC ACTIVITY AND CYP2C19 GENE POLYMORPHISMS ON CLOPIDOGREL ANTIPLATELET EFFECT IN PATIENTS WITH ACUTE CORONARY SYNDROME UNDERGOING PERCUTANEOUS CORONARY INTERVENTION
by: K. B. Mirzaev, et al.
Published: (2015-09-01)

Study of the effect of anxiolytic GML-1 on the activity of cytochrome CYP2C9 and CYP1A2 isoforms
by: O. G. Gribakina, et al.
Published: (2019-02-01)

Polymorphisms of CYP1A1, CYP1A2, CYP19, and SULT1A1 genes in women with early miscarriage
by: I. N. Noskova, et al.
Published: (2019-12-01)

Tropoxine in the effective dose does not affect on activity of CYP2С9 and CYP1А2 isoforms of cytochrome P450 in rats
by: V. P. Zherdev, et al.
Published: (2017-11-01)

Effect of <i>CYP1A2</i>, <i>CYP2D6</i>, and <i>CYP3A4</i> Variation on Antipsychotic Treatment Outcomes
by: Lauren Varney, et al.
Published: (2025-06-01)

POLYMORPHISMS OF THE CYP1A1, CYP1A2, CYP19, AND SULT1A1 GENES ARE NOT ASSOCIATED WITH INFERTILITY IN WOMEN WITH GENITAL ENDOMETRIOSIS
by: LARISA N. Danilova, et al.
Published: (2018-09-01)

Modulating effect of Cu(II) complexes with enamine and tetrazole derivatives on CYP2C and CYP3A and their cytotoxic and antiproliferative properties in HepG2 spheroids
by: L. S. Klyushova, et al.
Published: (2022-12-01)

Computational drug–drug interaction prediction mediated by CYP450 isoforms of Ilaprazole coadministered with clopidogrel
by: Priyadharshini Ananthathandavan, et al.
Published: (2024-12-01)

The prevalence of CYP2D6*10 (100C>T, rs1065852) gene polymorphism in Russian patients with epilepsy (North-Western and Siberian Districts)
by: N. A. Sivakova, et al.
Published: (2019-12-01)

Association of polymorphic variants of <i>CYP2C19</i>, <i>P2RY12</i>, <i>ITGB3</i>, <i>ITGA2</i> and <i>eNOS3</i> genes with high residual platelet reactivity while taking clopidogrel and acetylsalicylic acid at different terms of myocardial infarction
by: T. P. Pronko, et al.
Published: (2023-07-01)

Biochemical markers and cells count in peripheral blood in patients with tuberculosis according to CYP2C9 genotype
by: P. B. Antonenko
Published: (2014-04-01)

DISTRIBUTION OF POLYMORPHIC VARIANTS OF THE CYP1A1 AND CYP1A2 GENES IN THE MONGOLOID AND CAUCASOID POPULATION OF THE SOUTH OF KUZBASS
by: Фаина Анисимовна Лузина, et al.
Published: (2021-08-01)

GENOTYPE -786CC OF THE ENDOTHELIAL NITRIC OXIDE SYNTHASE GENE NOS3 AS A FACTOR OF ADVERSE CORONARY HEART DISEASE COURSE AND INCREASED ON-TREATMENT PLATELET AGGREGATION
by: E. F. Muslimova, et al.
Published: (2017-11-01)

CYP2D6 genotyping in the daily routine of a psychiatric hospital – pharmacoeconomic evaluation
by: A. A. Kurylev, et al.
Published: (2018-05-01)

THE SIGNIFICANCE OF PHARMACOGENETIC CYP2C19 TESTING FOR PERSONALIZATION OF THE ANTIPLATELET THERAPY IN CARDIOLOGY PRACTICE
by: K. B. Mirzaev, et al.
Published: (2015-09-01)

The Effect of Polymorphisms in the CYP2D6 and CYP2C9 Genes on the Clinical Efficacy of Tramadol and Ketorolac When Using the Accelerated Recovery Protocol in Patients With Uncomplicated Acute Calculous Cholecystitis Who Underwent Cholecystectomy
by: A. A. Muradyan, et al.
Published: (2020-10-01)

GENETICS OF CLOPIDOGREL RESISTANCE: RECENT DATA
by: K. B. Mirzaev, et al.
Published: (2015-10-01)

Impact of <i>CYP2C9, CYP2C19</i> and <i>ABCB1</i> genetic polymorphisms on antiepileptic drug safety and efficacy
by: N. A. Galankin, et al.
Published: (2025-05-01)

ASSOCIATION OF THE GENE CYP11B2 WITH THE RISK OF ESSENTIAL HYPERTENSION AND ATHEROTHROMBOTIC COMPLICATIONS
by: E. M. Zelenskaya, et al.
Published: (2016-06-01)

Pharmacogenetic and Clinical Predictors of Clopidogrel Insufficiency in a Patient with Atherosclerosis Obliterans of the Lower Extremities: Clinical Case
by: M. A. Andreyanova, et al.
Published: (2018-11-01)

CLINICAL SIGNIFICANCE OF STUDYING GENETIC POLYMORPHISM OF THE Р450 CYP2C9 AND CYP2C19 DETOXIFYING ENZYME GENES IN EPILEPTIC CHILDREN
by: O. V. Guzeva, et al.
Published: (2016-05-01)

INTERRELATION OF ANTIHYPERTENSIVE EFFECT OF COMBINATION OF VALSARTAN AND AMLODIPINE WITH VARIOUS POLYMORPHIC VARIANTS OF GENES CYP2C9 AND CYP11B2 IN PATIENTS WITH OBESITY
by: K. Yu. Lazarev, et al.
Published: (2018-05-01)

Impact of CYP2A6 genetic polymorphism on letrozole efficacy in Iraqi women with polycystic ovary syndrome
by: Nawar R. Kareem, BPharm, et al.
Published: (2025-08-01)

Genetic polymorphism of CYP1A1 and CYP2D6 in populations of Buryats, Teleuts and Russians of Eastern Siberia
by: L. E. Tabikhanova, et al.
Published: (2018-04-01)

Halloween genes AhCYP307A2 and AhCYP314A1 modulate last instar larva–pupa–adult transition, ovarian development and oogenesis in Agasicles hygrophila (Coleoptera: Chrysomelidae)
by: Ji-su JIN, et al.
Published: (2023-03-01)

ACC/AHA CLOPIDOGREL CLINICAL ALERT. WHAT MUST BE MODERN ANTIPLATELET THERAPY?
by: S. J. Martsevich
Published: (2016-01-01)

PERSONALIZED APPROACH TO TREATMENT OF CHRONIC INFLAMMATORY DISEASES OF THE UPPER GASTROINTESTINAL TRACT IN CHILDREN WITH CYP2C19 POLYMORPHISM ACCOUNT
by: E. V. Dudnikova, et al.
Published: (2015-12-01)

Heat stress-induced CYP1A2 upregulation in sow ovarian granulosa cells
by: Tae-Gyun Kim, et al.
Published: (2025-06-01)

Quantitative morphological characteristics of intravascular platelet activity in patients with diabetes mellitus type 2 with arterial hypertension under losartan treatment
by: Dzyak G.V., et al.
Published: (2012-01-01)

Evaluation of the relationship between the minimum steady-state concentration of angiotensin II receptor blockers and polymorphic markers of CYP2C9 (Arg144Cys), CYP2C9 (IlE359Leu), AGTR1 (A1166C), AGT (Met235Thr, C4072T), ACE (I/D), CYP11B2 (C-344T) genes and office arterial pressure
by: E. V. Rebrova, et al.
Published: (2025-03-01)

CYP2D6 genotype and outcome in tamoxifen treated early breast cancer
by: Linda Thorén, et al.
Published: (2025-07-01)

Clinical and Laboratory Predictors of Major Adverse Cardiac Events in Patients with Ischemic Heart Disease Following Elective Percutaneous Coronary Intervention
by: E. Z. Golukhova, et al.
Published: (2016-11-01)

Pharmacogenetic testing of allelic variants of the CYP2D6 gene in hormone positive breast cancer
by: L. N. Lyubchenko, et al.
Published: (2017-10-01)

Clinical Significance of Cytochrome P4502C19 (681G/A) Gene Polymorphism in Residents of the Trans-Baikal Territory in Treatment of Acid-Dependent Diseases
by: A. A. Zhilina, et al.
Published: (2022-03-01)